Patients' understanding of the reasons for starting and discontinuing inhaled corticosteroids.

Patients' understanding of the reasons for starting and discontinuing inhaled corticosteroids. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Patients' understanding of the reasons for starting and discontinuing inhaled corticosteroids. Abstract Text:

AIM: Although early discontinuation of treatment in new users of inhaled corticosteroids (ICS) has been widely discussed, the reasons for stopping have not been investigated in depth. We aimed to describe reasons for discontinuation from a patient's perspective in relation to their experience of symptoms at the time of the investigation. METHODS: A cross-sectional study among new users that discontinued ICS use in the Netherlands was performed. Patients were interviewed by telephone, aiming to identify the symptoms for which they were prescribed ICS, the reasons for discontinuing treatment and the respiratory symptoms patients still experienced at the time of the survey. In addition, automated dispensing records of all patients were retrieved. RESULTS: From 287 eligible patients, 230 (80.1%) were interviewed. Only 22 patients (9.6%) mentioned asthma as the reason for a first ICS prescription. A decrease in symptoms was the main reason for discontinuation (45%). Thirty patients (13%) reported clinically significant residual symptoms. These patients reported more seasonal variation of symptoms and were more often prescribed short-acting beta(2)-agonists. CONCLUSIONS: The majority of patients mentioned a wide range of symptoms and conditions, other than asthma or chronic obstructive pulmonary disease, as the reason for the start of ICS therapy. Most of these conditions may be expected to be of short duration. Not surprisingly a decrease in symptoms was the main, and justifiable, reason for discontinuing ICS. However, a non-negligible proportion of patients reported residual symptoms that suggest the need of continued ICS use. Physicians and pharmacists could cooperate in identifying those patients for which ICS are really indicated and motivate them to continue the use of ICS.

Patients' understanding of the reasons for starting and discontinuing inhaled corticosteroids. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Patients' understanding of the reasons for starting and discontinuing inhaled corticosteroids. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: British journal of clinical pharmacology

VOLUME: 66

Page Numbers: 255-60

Journal Abbreviation:

ISSN: 1365-2125

DAY: 22

MONTH: Aug

YEAR: 2008

Patients' understanding of the reasons for starting and discontinuing inhaled corticosteroids. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7503323

Patients' understanding of the reasons for starting and discontinuing inhaled corticosteroids. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Patients' understanding of the reasons for starting and discontinuing inhaled corticosteroids. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Patients' understanding of the reasons for starting and discontinuing inhaled corticosteroids.

AFFILIATION: Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Br J Clin Pharmacol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Patients' understanding of the reasons for starting and discontinuing inhaled corticosteroids Related Publications

• Changes in beta-adrenergic responses as a consequence of infection with micro-organisms.
• Characterization of the topography of vacuum-deposited films. 1: Light scattering.
• Diversity and activity of biosurfactant-producing Pseudomonas in the rhizosphere of black pepper in Vietnam.
• Diversity of Cultivated Endophytic Bacteria from Sugarcane: Genetic and Biochemical Characterization of Burkholderia cepacia Complex Isolates.
• Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy.
• Involvement of the ABC transporter BcAtrB and the laccase BcLCC2 in defence of Botrytis cinerea against the broad-spectrum antibiotic 2,4-diacetylphloroglucinol.
• Massetolide A Biosynthesis in Pseudomonas fluorescens.
• Patients' understanding of the reasons for starting and discontinuing inhaled corticosteroids.
• [Saliva and intensity modulated radiotherapy]